Ad is loading...
PAUG
Price
$38.27
Change
-$0.19 (-0.49%)
Updated
Nov 15 closing price
XTR
Price
$32.89
Change
-$0.60 (-1.79%)
Updated
Nov 15 closing price
Ad is loading...

PAUG vs XTR

Header iconPAUG vs XTR Comparison
Open Charts PAUG vs XTRBanner chart's image
Innovator U.S. Equity Power BufferETFAug
Price$38.27
Change-$0.19 (-0.49%)
Volume$30.39K
CapitalizationN/A
Global X S&P 500® Tail Risk ETF
Price$32.89
Change-$0.60 (-1.79%)
Volume$330
CapitalizationN/A
PAUG vs XTR Comparison Chart
Loading...
PAUG
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
PAUG vs. XTR commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PAUG is a StrongSell and XTR is a Buy.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PAUG has more net assets: 851M vs. XTR (2.63M). XTR has a higher annual dividend yield than PAUG: XTR (21.946) vs PAUG (14.684). PAUG was incepted earlier than XTR: PAUG (5 years) vs XTR (3 years).
PAUGXTRPAUG / XTR
Gain YTD14.68421.94667%
Net Assets851M2.63M32,308%
Total Expense RatioN/AN/A-
Turnover0.00N/A-
Yield0.000.99-
Fund Existence5 years3 years-
TECHNICAL ANALYSIS
Technical Analysis
PAUG
RSI
ODDS (%)
Bearish Trend 3 days ago
52%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
42%
Momentum
ODDS (%)
Bullish Trend 3 days ago
71%
MACD
ODDS (%)
Bullish Trend 3 days ago
72%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
59%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
64%
Advances
ODDS (%)
Bullish Trend 6 days ago
66%
Declines
ODDS (%)
Bearish Trend 3 days ago
55%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
54%
Aroon
ODDS (%)
Bullish Trend 3 days ago
62%
View a ticker or compare two or three
Ad is loading...
PAUG
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SLB43.18-0.27
-0.62%
Schlumberger Limited
NUVL86.88-3.30
-3.66%
Nuvalent
AKBA1.79-0.07
-3.76%
Akebia Therapeutics
BNGO0.25-0.01
-3.83%
Bionano Genomics
VRDN20.14-1.50
-6.93%
Viridian Therapeutics